How can we design better vaccines to prevent HIV infection in women?

por Rafferty, Hannah, Sibeko, Sengeziwe, Rowland-Jones, Sarah
Publicado 2014

Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Randomized-Controlled Trial

por Matthews, Lynn T., Sibeko, Sengeziwe, Mansoor, Leila E., Yende-Zuma, Nonhlanhla, Bangsberg, David R., Karim, Quarraisha Abdool
Publicado 2013

Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial

por Karim, Quarraisha Abdool, Kharsany, Ayesha BM, Frohlich, Janet A, Baxter, Cheryl, Yende, Nonhlanhla, Mansoor, Leila E, Mlisana, Koleka P, Maarschalk, Silvia, Arulappan, Natasha, Grobler, Anneke, Sibeko, Sengeziwe, Omar, Zaheen, Gengiah, Tanuja N, Mlotshwa, Mukelisiwe, Samsunder, Natasha, Abdool Karim, Salim S
Publicado 2011